Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization
Clinical trial NCT06596291 · RECRUITING
Trial details
- NCT number
- NCT06596291
- Sponsor
- Cyllene Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-08
- Primary completion
- 2027-06-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.